| Literature DB >> 18573222 |
Joelle Mermod1, Lorenz Fischer, Lukas Staub, André Busato.
Abstract
BACKGROUND: The main objective of this study was to assess and compare patient satisfaction with Neural Therapy (NT) and conventional medicine (COM) in primary care for musculoskeletal diseases.Entities:
Mesh:
Year: 2008 PMID: 18573222 PMCID: PMC2443106 DOI: 10.1186/1472-6882-8-33
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Figure 1Flowchart of sampling procedures.
Socio-demography and health status of patient population
| 241 | 164 | ||||||
| 55.42 | 53.28 | ||||||
| 150 | 62.24 | 55.9–68.6 | 126 | 76.83 | 71–82.7 | ||
| 20.5 | 14.9–26.1 | 24.7 | 16.4–32.9 | ||||
| 8 | 3.45 | 1.03–5.86 | 4 | 2.52 | 0.00–5.32 | ||
| 33 | 14.22 | 10.19–18.26 | 27 | 16.98 | 11.95–22.01 | ||
| 126 | 54.31 | 47.95–60.67 | 63 | 39.62 | 33.48–45.76 | ||
| 53 | 22.84 | 17.75–27.94 | 59 | 37.11 | 27.06–47.15 | ||
| 12 | 5.17 | 2.40–7.94 | 6 | 3.77 | 0.00–8.15 | ||
| 47.7 | 32.5–63 | 72.9 | 48.5–97.2 | ||||
| 116 | 48.1 | 42.1–54.2 | 116 | 70.7 | 62.8–78.7 | ||
| 77 | 34.4 | 29.3–39.5 | 60 | 37.7 | 31.3–44.1 | ||
a 95% confidence limits
bpatient rated
Main Diagnoses
| M00–25 | Arthropathies | 60 | 24.9 | 18.7–31.1 | 30 | 18.3 | 10.8–25.8 |
| M30–36 | Systemic connective tissue disorders | 4 | 1.66 | 0.1–3.2 | 3 | 1.8 | 0.2–3.4 |
| M40–54 | Dorsopathies | 95 | 39.4 | 32.5–46.3 | 76 | 46.3 | 35.1–57.6 |
| M60–79 | Soft tissue disorders | 72 | 29.9 | 23.3–36.4 | 49 | 29.9 | 20.2–39.5 |
| M80–94 | Osteopathies and chondropathies | 5 | 2.07 | 0.4–3.8 | 2 | 1.2 | 0.0–3.0 |
| M95–99 | Other disorders of the musculoskeletal system and connective tissue | 5 | 2.07 | 0.4–3.8 | 4 | 2.4 | 0.0–5.4 |
| 95 | 39.4 | 32.5–46.3 | 88 | 53.7 | 35.1–57.6 | ||
| M43 | Other deforming dorsopathies | 4 | 1.7 | 1 | 0.6 | ||
| M45 | Ankylosing spondylitis | 1 | 0.4 | 0 | 0 | ||
| M47 | Spondylosis | 3 | 1.2 | 3 | 1.8 | ||
| M48 | Other spondylopathies | 3 | 1.2 | 1 | 0.6 | ||
| M51 | Other intervertebral disc disorders | 6 | 2.5 | 4 | 2.4 | ||
| M53 | Other dorsopathies, not elsewhere classified | 3 | 1.2 | 15 | 9.2 | ||
| M54 | Dorsalgia | 75 | 31.1 | 52 | 31.7 | ||
| Comorbid conditions | |||||||
| 101 | 41.9 | 34.3–49.6 | 51 | 31.1 | 20.8–41.4 | ||
| 61 | 25.3 | 19.8–30.8 | 58 | 35.4 | 29.4–41.3 | ||
| 79 | 32.8 | 25–40.6 | 55 | 33.5 | 21.7–45.4 | ||
a 95% confidence limits
Patient evaluations
| 30 | 12.9 | 7.8–18.1 | 12 | 7.4 | 3.1–11.7 | ||
| 68 | 29.3 | 23.5–35.2 | 64 | 39.5 | 32.9–46.1 | ||
| 63 | 27.2 | 20.8–33.5 | 47 | 29.0 | 22.0–36.0 | ||
| 61 | 26.3 | 20.7–31.9 | 34 | 21 | 16.2–25.8 | ||
| 9 | 3.9 | 1.4–6.4 | 4 | 2.5 | 0.2–4.7 | ||
| 1 | 0.4 | 0–1.3 | 1 | 0.6 | 0–1.8 | ||
| 33 | 15 | 9.6–20.5 | 40 | 24.8 | 18.5–31.2 | ||
| 66 | 29.5 | 22.7–36.2 | 66 | 41.3 | 35.9–46.6 | ||
| 29 | 12.9 | 8.4–17.5 | 17 | 10.6 | 8.2–12.9 | ||
| | 4 | 13.8b | 1.6–26.0 | 7 | 41.2 | 13.1–69.2 | |
| 18 | 62.1 | 45.2–78.9 | 5 | 29.4 | 6.9–52.0 | ||
| 7 | 24.1 | 7.6–40.7 | 5 | 29.4 | 7.7–51,2 | ||
| 38 | 17.7 | 13.1–22.3 | 59 | 37.6 | 29.1–46.1 | ||
| 16 | 7.4 | 3.8–11.1 | 9 | 5.7 | 2.5–9.0 | ||
| 161 | 74.9 | 70.3–79.5 | 89 | 56.7 | 47.0–66.4 | ||
| 59 | 29.7 | 22.2–37.1 | 62 | 44.3 | 36.0–52.6 | ||
| 77 | 38.7 | 31.0–46.4 | 55 | 39.3 | 29.9–48.7 | ||
| 39 | 19.6 | 13.7–25.5 | 12 | 8.6 | 4.1–13.1 | ||
| 24 | 12.1 | 7.0–17.1 | 11 | 7.9 | 3.1–12.6 | ||
*significant difference (p < 0.05) in the proportion of the most favorable answer option between NT and COM in a multivariate logistic model (age, gender and chronicity controlled)
a 95% confidence limits
b percentage of patients with adverse side effects within group
Patient expectations
| 112 | 46.5 | 40.1–53.8 | 82 | 50.0 | 41.3–58.7.0 | ||
| 128 | 53.1 | 47.5–58.8 | 86 | 52.4 | 42.4–62.5 | ||
| 5 | 2.1 | 0.3–3.8 | 2 | 1.2 | 0.0–3.5 | ||
| 22 | 9.1 | 5.1–13.1 | 30 | 18.3 | 11.2–25.4 | ||
| 2 | 0.8 | 0.0–2.0 | 4 | 2.4 | 0.3–4.5 | ||
a 95% confidence limits
Patient satisfaction (EUROPEP)
| 1. | 60.6 | 53.9–67.3 | 70.3 | 53.3–87 |
| 2. | 58.6 | 52.1–65 | 72 | 60–83.9 |
| 3. | 61.1 | 53.2–69 | 71.9 | 59–84.8 |
| 4. | 55.7 | 48.1–63.4 | 64.7 | 54.2–75.1 |
| 5. | 65.8 | 59.1–72.5 | 73.7 | 61.1–86.3 |
| 6. | 69.5 | 62.4–76.7 | 83.1 | 74.6–91.6 |
| 7. | 16.1 | 10.3–22 | 26.6 | 20.3–32.9 |
| 8. | 27 | 20.2–33.8 | 40.7 | 32.7–48.8 |
| 9. | 50.5 | 43.1–57.8 | 68.4 | 59.6–77.1 |
| 10. | 47.1 | 40.7–53.4 | 55.7 | 38.8–72.6 |
| 11. | 43 | 34.2–51.9 | 54.3 | 41.9–66.7 |
| 12. | 57.1 | 50.2–64.1 | 72.7 | 64.9–80.5 |
| 13. | 55.4 | 48.1–62.7 | 71.2 | 60.4–81.9 |
| 14. | 47.8 | 40.3–55.2 | 57.9 | 44.6–71.2 |
| 15. | 44.1 | 37.2–51.1 | 61.7 | 51.4–71.9 |
| 16. | 53.2 | 45.2–61.2 | 63.5 | 50.3–76.7 |
| 17. | 53.4 | 44.9–61.8 | 76.8 | 64.9–88.6 |
| 18. | 64.3 | 57.9–70.7 | 74.8 | 65.8–83.9 |
| 19. | 1.3 | 0–2.7 | 1.2 | 0.0–3.1 |
| 20. | 73.5 | 65.9–81.1 | 69.1 | 56.5–81.8 |
| 21. | 54.9 | 46.4–63.3 | 58.9 | 42.3–75.6 |
| 22. | 36.3 | 27.8–44.8 | 42.8 | 31.4–54.2 |
| 23. | 67.7 | 59.7–75.6 | 70.2 | 61.5–79.0 |
*significant difference in the proportion of the most favorable answer option (p < 0.05) between NT and COM in a multivariate logistic model (age, gender and chronicity controlled)
a 95% confidence limits